Mutant gene discovery in Jews may stop brain damage

BGU research finds gene in Jews of Moroccan and Iraqi origin that may cause serious mental retardation, epilepsy beginning at infancy.

By
October 11, 2010 06:03
1 minute read.
PROF. OHAD BIRK

PROF. OHAD BIRK 311. (photo credit: BGU)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

A mutant gene carried by one out of 40 Jews of Moroccan and Iraqi ancestries that – if found in both parents – may cause serious mental retardation and epilepsy beginning at infancy, has been discovered by a Ben- Gurion University of the Negev team.

As the disease is both severe and common, testing for these mutations will probably soon become a routine prenatal genetic screening test in these two populations so that future cases can be prevented, by carriers either not marrying each other or having children together, or by abortion or pre-genetic diagnosis to choose healthy embryos for in-vitro fertilization.

Be the first to know - Join our Facebook page.


Prof. Ohad Birk and doctoral student Orly Agamy of the National Institute for Biotechnology in the Negev at BGU and colleagues at Soroka University Medical Center in Beersheba demonstrated the first human disease associated with a defect in the production of the 21st amino acid, selenocysteine (SEC). Their work was published in the October 8 edition of the American Journal of Human Genetics.

They believe that further research will identify other mutations in the same gene as the cause in other ethnic communities of mental retardation with epilepsy. As the disease is progressive, elucidation of its molecular mechanisms might open new venues to treatment, preventing disease progression.

The human genetic code is made up of 20 amino acids that are the building blocks of all proteins in the human body. However, in recent years it became apparent that a 21st amino acid exists: selenium entering the body in food is incorporated in the human tissues into what is known as selenocysteine. Healthy expression of seleoproteins is crucial for the function of the neurons, they write.

This 21st amino acid is unique in that it is encoded by what is normally a stop codon – a DNA sequence that normally instructs the protein building system to end the chain of amino acids, thus terminating the generated protein. In contrast with most genes, some 25 genes have a unique component that manipulates the stop codon so that instead of terminating the evolving protein chain, it inserts at that point a SEC building block.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

[illustrative photo]
September 24, 2011
Diabetes may significantly increase risk of dementia

By UNIVERSITY OF MICHIGAN HEALTH SYSTEM